Author: EMCDDA

EMCDDA raised concerns over complex stimulant market and plethora of powders and pills in its 2012 anual report. According to this report, Europe is faced with an increasingly complex stimulant market, in which consumers are confronted with a wide variety of powders and pills.
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.

A review of the monitoring of drug-related acute emergencies in 30 European countries, published in April 2014 by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 

The report aims:

• To present a summarised literature review of the most common health problems caused by cocaine use, focused on cardiovascular, cerebrovascular and neurological problems.
• To describe the sources of information on drug- and cocaine-related health emergencies in Europe and analyse relevant data from European countries’ recent annual National reports to the EMCDDA.
• To discuss the limitations of the data collected on cocaine-related acute emergencies and the public health implications of the cocaine-related results.
• To discuss the broader issue of using data from emergency settings to help monitor problems related to drug use.

How many new drugs were detected in Europe over the last year? Is cannabis getting stronger? How many Europeans have ever used an illicit drug? What are the latest drug policy developments in the region? These are just some of the questions explored in the European Drug Report: Trends and developments. This report provides a top-level overview of the long-term drug-related trends and developments at European level, while homing in on emerging problems in specific countries. Such a perspective is valuable, as it allows differing national experiences to be understood within the broader European context.